{"id":"W4379332790","doi":"10.1200/jco.2023.41.16_suppl.tps4206","title":"STAR-221: A randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; FOLFOX; Internal medicine; Oncology; Oxaliplatin; Chemotherapy; Gastroenterology; Cancer; Immunotherapy; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005306931,0.00034681,0.003580482,0.0005050801,0.0000661666,0.00005568383,0.0002421426,0.0001980615,0.0001540714],"category_scores_gemma":[0.002587584,0.0002430845,0.0002314941,0.0006195077,0.0005520628,0.0003567322,0.000176957,0.0006868212,0.000002287028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001616638,"about_ca_system_score_gemma":0.0007793781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001776794,"about_ca_topic_score_gemma":0.0002046248,"domain_scores_codex":[0.9947733,0.0007608582,0.002990216,0.0004780502,0.0004871741,0.0005104179],"domain_scores_gemma":[0.9930712,0.004103571,0.001832674,0.0002489778,0.0002999555,0.0004436077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8425899,0.002621278,0.01138565,0.0001716315,0.001132175,0.0009574098,0.0001903109,0.000008919968,0.000018483,0.00001963934,0.001251834,0.1396528],"study_design_scores_gemma":[0.9185393,0.05577632,0.02046704,0.0001858803,0.001204534,0.0001740893,0.0004013113,0.001534009,0.00001267482,0.00009382705,0.001470569,0.0001403761],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898199,0.002705392,0.0002846099,0.003654495,0.0007613059,0.002623515,0.000009432207,0.00001931167,0.0001219693],"genre_scores_gemma":[0.9533189,0.03298924,0.01092719,0.00126453,0.000456574,0.00006324797,0.00001389482,0.00005740317,0.0009090143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1395124,"threshold_uncertainty_score":0.99127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1123804602371185,"score_gpt":0.4602107707478902,"score_spread":0.3478303105107716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}